These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18249559)

  • 1. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
    Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
    Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large scale purification and characterization of recombinant human autotaxin/lysophospholipase D from mammalian cells.
    Song Y; Dilger E; Bell J; Barton WA; Fang X
    BMB Rep; 2010 Aug; 43(8):541-6. PubMed ID: 20797316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
    Kawagoe H; Stracke ML; Nakamura H; Sano K
    Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of autotaxin/lysophospholipase D activity.
    Morris AJ; Smyth SS
    Methods Enzymol; 2007; 434():89-104. PubMed ID: 17954243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an activity-based probe for autotaxin.
    Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
    Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.
    Nakamura K; Igarashi K; Ide K; Ohkawa R; Okubo S; Yokota H; Masuda A; Oshima N; Takeuchi T; Nangaku M; Okudaira S; Arai H; Ikeda H; Aoki J; Yatomi Y
    Clin Chim Acta; 2008 Feb; 388(1-2):51-8. PubMed ID: 17963703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin promotes the expression of matrix metalloproteinase-3 via activation of the MAPK cascade in human fibrosarcoma HT-1080 cells.
    Haga A; Nagai H; Deyashiki Y
    Cancer Invest; 2009 May; 27(4):384-90. PubMed ID: 19212832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.
    Saunders LP; Ouellette A; Bandle R; Chang WC; Zhou H; Misra RN; De La Cruz EM; Braddock DT
    Mol Cancer Ther; 2008 Oct; 7(10):3352-62. PubMed ID: 18852138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.
    Yuelling LM; Fuss B
    Biochim Biophys Acta; 2008 Sep; 1781(9):525-30. PubMed ID: 18485925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, regulation and function of autotaxin in thyroid carcinomas.
    Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
    Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
    Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
    Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
    Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
    Nam SW; Clair T; Kim YS; McMarlin A; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2001 Sep; 61(18):6938-44. PubMed ID: 11559573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.
    Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA
    FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
    Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
    Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation.
    Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM
    Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
    Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
    Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
    Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
    Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
    Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
    Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.